Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Andrew X. Zhu, Alexander R. Abbas, Marina Ruiz de Galarreta, Yinghui Guan, Shan Lu, Hartmut Koeppen, Wenjun Zhang, Chih‐Hung Hsu, Aiwu Ruth He, Baek‐Yeol Ryoo, Thomas Yau, Ahmed O. Kaseb, Adam M. Burgoyne, Farshid Dayyani, Jessica Spahn, Wendy Verret, Richard S. Finn, Han Chong Toh, Amaia Lujambio, Yulei Wang
Topics & Concepts
AtezolizumabBevacizumabMedicineAngiogenesisHepatocellular carcinomaCancer researchSorafenibVascular endothelial growth factorOncologyImmunotherapyInternal medicineRegorafenibCancerImmunologyColorectal cancerNivolumabVEGF receptorsChemotherapyCancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and PrognosisImmunotherapy and Immune Responses